We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives. CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma.
Develop integrated external communications strategies that support commercial and medical objectives and position CSL as a trusted leader in plasma economics and healthcare innovation. Build and maintain strong relationships with pan‑European and DACH journalists.